Defence Therapeutics Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-22
Interim MD&A - English.pdf
Results 2026-05-22
Interim financial statements/report – English.pdf
News 2026-05-19
Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities
News release - English.pdf
News 2026-03-27
Early warning report.pdf
Ownership 2026-03-27
EARLY WARNING REPORT FILED PURSUANT TO NATIONAL INSTRUMENT 62-103
Press release - English.pdf
Transactions 2026-03-20 Financing
Defence Therapeutics Announces Warrant Terms Amendment
News release - English.pdf
News 2026-03-17
Report of exempt distribution (45-106F1) (amended).pdf
Transactions 2026-03-12 Financing
Defence Therapeutics Inc. Closes Private Placement for Aggregate Gross Proceeds of $9,595,000.25
Material change report - English.pdf
News 2026-03-12
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-09 Financing
Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000
News release - English.pdf
News 2026-03-02
Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
News release - English.pdf
Transactions 2026-02-27 Financing
Defence Therapeutics Announces Private Placement of Units for Proceeds of up to $11 Million
News release - English.pdf
Results 2026-02-20 Financials
Interim MD&A - English.pdf
Results 2026-02-20 Financials
Interim financial statements/report – English.pdf
News 2026-02-10
Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
News release - English.pdf
News 2026-02-04
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
News release - English.pdf
News 2026-01-28
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
News release - English.pdf
News 2026-01-21
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
News release - English.pdf
Results 2025-11-27 Financials
Interim MD&A - English.pdf
Results 2025-11-27 Financials
Interim financial statements/report – English.pdf
Transactions 2025-11-26 Financing
Defence Therapeutics Inc. Announces Conversion of 8% Convertible Debentures into Common Shares
Material change report - English.pdf
Transactions 2025-11-21 Financing
Defence Therapeutics Announces Convertible Debenture Conversion
News release - English.pdf
News 2025-11-19
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology
News release - English.pdf
News 2025-11-10
Other.pdf
News 2025-11-10
Other.pdf
News 2025-11-06
News release - English.pdf
News 2025-11-04
News release - English.pdf
Results 2025-10-28 Financials
Annual MD&A - English.pdf
Results 2025-10-28 Financials
Audited annual financial statements – English.pdf
News 2025-10-23
News release - English.pdf
News 2025-10-06
News release - English.pdf
News 2025-10-02
News release - English.pdf
News 2025-09-23
News release - English.pdf
News 2025-09-19
Report of exempt distribution (45-106F1).pdf
News 2025-09-16
News release - English.pdf
News 2025-09-15
News release - English.pdf
News 2025-09-02
News release - English.pdf
News 2025-08-23
News release - English.pdf
News 2025-07-14
News release - English.pdf
News 2025-06-09
News release - English.pdf
News 2025-06-02
News release - English.pdf